The DES Center

Filter Your Results




Medinol's EluNIR DES Receives CE Mark Approval

October 26, 2017 -- Medinol USA announced that it has obtained European CE Mark approval for its EluNIR ridaforolimus-eluting coronary stent system, which features a low metal…

Cardinal Health’s Cordis Business Will Distribute Medinol’s Coronary Stent Portfolio in the United States

October 18, 2017 -- Cardinal Health recently advised that it has entered into a long-term, exclusive distribution agreement with Medinol that enables Cordis, Cardinal Health&r…

Enrollment Begins in Biotronik's BIOVITESSE Trial

October 9, 2017 -- Biotronik announced the start of enrollment of the BIOVITESSE trial, a coronary stent trial to assess the safety and clinical performance of a new coronary …

ESC Issues 2017 Guidelines on STEMI Management

September 5, 2017 -- The European Society of Cardiology (ESC) recently announced the publication of its 2017 guidelines on the management of acute myocardial infarction in pat…

One-Year Data Presented From BIOFLOW-V Pivotal Trial of Biotronik's Orsiro DES

August 28, 2017 -- Biotronik announced data from the BIOFLOW-V randomized trial comparing the company's Orsiro drug-eluting stent (DES) and the Xience DES (Abbott Vascular…

BIONICS Evaluates Safety and Efficacy of Medinol's Ridaforolimus-Eluting Stent

August 18, 2017 -- Primary results from the BIONICS trial were published online ahead of print by David E. Kandzari, MD, et al in Circulation. BIONICS was designed to determin…

Medtronic Initiates Global Study of 1-Month DAPT After Implantation of Resolute Onyx DES

August 14, 2017 -- Medtronic announced a global randomized clinical trial that will evaluate 1-month dual antiplatelet therapy (DAPT) in patients who have undergone implantati…

Reva Medical to Market Its Fantom Drug-Eluting Bioresorbable Scaffold as Boston Scientific’s Distribution Option Expires

August 7, 2017 -- Reva Medical, Inc. announced the expiration of Boston Scientific Corporation's exclusive right to negotiate for distribution of Reva Medical's corona…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.